Policy Recommendations North Carolina

2019-2020 Improvements and Recommendations for North Carolina

In 2019, North Carolina state lawmakers introduced comprehensive medical cannabis legislation, however the bill was not provided a hearing before the legislature adjourned in 2020. Lawmakers also introduced legislation in 2019 to add autism, Crohn's disease, multiple sclerosis, mitochondrial disease and other conditions to the state's list of eligible conditions required to participate in the state's limited CBD-only access model. ASA recommends that North Carolina lawmakers approve comprehensive medical cannabis legislation in 2021. Such a system should authorize robust patient access, organize patient legal protections from housing and education to parental and employment rights, and organize an in-state licensing regime for commercial cannabis cultivators, manufacturers, testing laboratories, distributors and medical retailers.